Data / Form D filings / Mind Pharmaceuticals Corp
Mind Pharmaceuticals Corp: Form D filing
Mind Pharmaceuticals Corp, a biotechnology company in New Haven, CT, filed a Form D with the SEC in 2025. The latest, on May 15, 2025, reports $50,000 sold of a $8 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12-R, 100 YORK STREET, New Haven, CT, 06511
- Phone
- (908) 331-2511
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 2068220
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 15, 2025 | New notice | $8,000,000 | $50,000 | $7,950,000 | 1 | May 1, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Prakash Krishna Mandgi | Executive Officer, Director | |
| Krishna Ravindranathan | Executive Officer, Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of May 12, 2025 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mind Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.